On February 27, 2024 Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) reported that management will be participating in the following upcoming investor conferences during the month of March (Press release, Aurinia Pharmaceuticals, FEB 27, 2024, View Source [SID1234640507]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

TD Cowen’s 44th Annual Health Care Conference taking place March 4 – 6, 2024, at the Marriott Copley Place in Boston, MA. Aurinia management will host one-on-one meetings with investors and will participate in a fireside chat and Q&A session on Tuesday, March 5, from 1:30-2:00 PM Eastern Time. A live webcast of the session will be available on the Investor section of Aurinia’s website, which can be found here.

Leerink Partners Global Biopharma Conference taking place March 11-13, 2024, at the Fontainebleau Miami Beach. Aurinia management will host one-on-one meetings with investors and will participate in a fireside chat and Q&A session on Tuesday, March 12, from 8:40 – 9:10 AM Eastern Time. The session will not include a webcast.